← FDA Drug Approvals (Drugs@FDA)

RIFAMPIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA PHARMS · Approved 2016-03-03

Drug application

FDA Application #

ANDA205039

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIFAMPIN

Generic name

RIFAMPIN

Active ingredients

RIFAMPIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HIKMA PHARMS

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2016-03-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown